Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · BILL · 118th Congress · H.R. 4697 (Introduced in House) — To amend the Public Health Service Act to reauthorize certain programs with respect to public health security and all... · Sec. 501

Sec. 501. Extended expiration dates for life-saving drugs

621 words·~3 min read·/bill/118/hr/4697/ih/section-501

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

The Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 301 et seq. ) is amended by inserting after section 506L of such Act ( 21 U.S.C. 356l ) the following new section: A manufacturer of a life-saving drug shall— submit to the Secretary data and information as required by subsection (b)(1); conduct and submit the results, data, and information generated by any studies required under subsection (b)(2); and make any labeling change described in subsection
(c)by the date specified by the Secretary pursuant to such subsection. The Secretary may issue an order requiring the manufacturer of a life-saving drug to submit, in such manner as the Secretary may prescribe, data and information from any stage of development of the drug that are adequate to assess the stability of the drug to determine the longest supported expiration date. If the data and information required pursuant to an order issued under paragraph
(1)are not available or are insufficient, as determined by the Secretary, the Secretary may issue an order requiring the manufacturer of the drug— to conduct studies, which may be a continuation of ongoing studies, to provide data and information adequate to assess the stability of the drug and to determine the longest supported expiration date; and to submit such data and information to the Secretary in such manner as the Secretary may prescribe in the order. The Secretary may issue an order requiring the manufacturer of a life-saving drug, by a date determined by the Secretary in consultation with the sponsor of the drug, to make any labeling change regarding the expiration date or storage and handling of the drug that the Secretary determines to be appropriate based on the data and information required to be submitted under this section or any other data and information available to the Secretary. In this section: The term life-saving drug means a drug, that is— a medical countermeasure; or on the drug shortage list under section 506E or determined by the Secretary to be at risk of shortage; and life-supporting; life-sustaining; or intended for use in the prevention or treatment of a debilitating disease or condition in humans or animals, including any such drug used in emergency medical care or during surgery or any such drug that is critical to the public health during a public health emergency declared by the Secretary under section 319 of the Public Health Service Act. The term medical countermeasure means a countermeasure as defined in section 565(a). Nothing in this section shall be construed as authorizing the Secretary to disclose any information that is a trade secret or confidential information subject to section 552(b)(4) of title 5, United States Code, or section 1905 of title 18, United States Code. . Section 301 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331 ), as amended by section 3503(a)(1)(A) of division FF of Public Law 117–328 , is amended by inserting at the end the following new subsection: The failure to comply with any order issued under section 506M. . Subsection
(b)of section 303 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 333 ) is amended by inserting at the end the following: If a manufacturer of a life-saving drug fails to submit data and information as required under section 506M(b)(1), fails to conduct or submit the data and information generated by studies as required under section 506M(b)(2), or fails to make a labeling change as required under section 506M(c), such manufacturer shall be subject to a civil penalty of not more than $10,000 for the first day on which the violation occurs and not more than $10,000 for each subsequent day on which the violation is not corrected. .
Connectionstraces to 5
Citation graph
cites case law
Sec. 501
Extended expiration dates for life-saving drugs
Cites 5Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.